| | | SIMVASTATIN IMP. A (EP) AS SODIUM SALT: (3R,5R)-7-[(1S,2S,6R,8S,8AR)-8-[(2,2-DIMETHYLBUTANOYL)OXY]-2,6-DIMETHYL-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT(TENIVASTATIN SODIUM SALT; SIMVASTATIN HYDROXY ACID SODIUM SALT),
CAS:79902-63-9
Formula: C25H38O5
CRM801115
418.57
MFCD00072007 SIMVASTATIN IMP. B (EP): (1S,3R,7S,8S,8AR)-8-[2-[(2R,4R)-4-(ACETYLOXY)-6-OXOTETRAHYDRO-2H-PYRAN-2-YL]ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE (SIMVASTATIN ACETATE ESTER), CRM STANDARD
CAS:79902-63-9
Formula: C25H38O5
CRM801116
418.57
MFCD00072007 SIMVASTATIN IMP. B (EP): (1S,3R,7S,8S,8AR)-8-[2-[(2R,4R)-4-(ACETYLOXY)-6-OXOTETRAHYDRO-2H-PYRAN-2-YL]ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE (SIMVASTATIN ACETATE ESTER), CRM STANDARD
CAS:145576-25-6
Formula: N/A
CRM801116
NULL SIMVASTATIN IMP. C (EP): (1S,3R,7S,8S,8AR)-3,7-DIMETHYL-8-[2-[(2R)-6-OXO-3,6-DIHYDRO-2H-PYRAN-2-YL]ETHYL]-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE (ANHYDROSIMVASTATIN), CRM STANDARD
CAS:210980-68-0
Formula: N/A
CRM801117
NULL SIMVASTATIN IMP. C (EP): (1S,3R,7S,8S,8AR)-3,7-DIMETHYL-8-[2-[(2R)-6-OXO-3,6-DIHYDRO-2H-PYRAN-2-YL]ETHYL]-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2,2-DIMETHYLBUTANOATE (ANHYDROSIMVASTATIN), CRM STANDARD
CAS:79902-63-9
Formula: C25H38O5
CRM801117
418.57
MFCD00072007 SIRP ALPHA (SIGNAL REGULATORY PROTEIN ALPHA, SIRPALPHA, SIRPA, SIGNAL REGULATORY PROTEIN ALPHA TYPE 1, SIGNAL REGULATORY PROTEIN ALPHA 1, SIRP ALPHA 1, SIRPALPHA1, SIGNAL REGULATORY PROTEIN ALPHA TYPE 2, SIRP ALPHA 2, SIRPALPHA2, SIRP ALPHA 3, BRAIN IMMUN
CM886940 SIRPA, CT (SIRPA, BIT, MFR, MYD1, SHPS1, SIRP, Tyrosine-protein phosphatase non-receptor type substrate 1, CD172, Inhibitory receptor SHPS-1, MyD-1, Signal-regulatory protein alpha-1, p84, CD172a)
CM1230788 SIRT1 (SIRTUIN (SILENT MATING TYPE INFORMATION REGULATION 2 HOMOLOG) 1 (S. CEREVISIAE), RP11-57G10.3, SIR2L1, OTTHUMP00000060745, SIR2ALPHA, SIR2-LIKE 1, SIRTUIN (SILENT MATING TYPE INFORMATION REGULATION 2, S. CEREVISIAE, HOMOLOG) 1, SIRTUIN 1, SIRTUIN T
CM1408871 SIRT1 (SIRTUIN (SILENT MATING TYPE INFORMATION REGULATION 2 HOMOLOG) 1 (S. CEREVISIAE), RP11-57G10.3, SIR2L1, OTTHUMP00000060745, SIR2ALPHA, SIR2-LIKE 1, SIRTUIN (SILENT MATING TYPE INFORMATION REGULATION 2, S. CEREVISIAE, HOMOLOG) 1, SIRTUIN 1, SIRTUIN T
CM1516820 Sirtuin 3 (Sirt3, Sirtuin 3 (Silent mating type information regulation 2, homolog) 3, 2310003L23Rik, AI848213, Sir2l3, NAD-dependent deacetylase Sirtuin-3, OTTMUSP00000027441, OTTMUSP00000027444, OTTMUSP00000027445, SIR2-like protein 3) (Biotin)
CM1081566 Sirtuin 3 (Sirt3, Sirtuin 3 (Silent mating type information regulation 2, homolog) 3, 2310003L23Rik, AI848213, Sir2l3, NAD-dependent deacetylase Sirtuin-3, OTTMUSP00000027441, OTTMUSP00000027444, OTTMUSP00000027445, SIR2-like protein 3) (FITC)
CM1084666 SKAP2, ID (SKAP2, PRAP, RA70, SAPS, SCAP2, SKAP55R, SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 2, PYK2/RAFTK-ASSOCIATED PROTEIN, RETINOIC ACID-INDUCED PROTEIN 70, SKAP55 HOMOLOG, SRC FAMILY-ASSOCIATED PHOSPHOPROTEIN 2, SRC KINASE-ASSOCIATED PHOSPHOPROTEIN 55-RE
CM1244190 SKP1 (S-PHASE KINASE-ASSOCIATED PROTEIN 1, CYCLIN-A/CDK2-ASSOCIATED PROTEIN P19, ORGAN OF CORTI PROTEIN 2, OCP-2, ORGAN OF CORTI PROTEIN II, OCP-II, RNA POLYMERASE II ELONGATION FACTOR-LIKE PROTEIN, SIII, TRANSCRIPTION ELONGATION FACTOR B, P19A, P19SKP1,
CM1542180 |
